Can Gamma Glutamylcysteine be Targeted for Therapeutic Purposes?
Yes, targeting gamma glutamylcysteine synthesis and its metabolic pathways holds therapeutic potential. For example, enhancing glutathione levels through precursors like gamma glutamylcysteine could mitigate oxidative stress in chronic diseases. Additionally, inhibitors of gamma-glutamylcysteine synthetase are being explored as potential treatments for conditions where excessive glutathione production contributes to disease progression.
